financetom
Business
financetom
/
Business
/
US halt on Rhode Island offshore wind project is unjustified, developer says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US halt on Rhode Island offshore wind project is unjustified, developer says
Sep 20, 2025 9:49 PM

Sept 18 (Reuters) - The owners of Revolution Wind said

the Trump administration's reasons for stopping work on its

Rhode Island offshore wind farm were "factually incorrect" and

only disclosed after it had ordered a halt to the project,

according to court documents filed on Thursday.

The filing in U.S. District Court for the District of

Columbia is part of a lawsuit brought earlier this month by

joint venture partners Orsted and Skyborn Renewables

challenging a stop-work order issued to Revolution Wind by the

Department of the Interior in August.

U.S. President Donald Trump has repeatedly criticized wind

energy as ugly, unreliable, and expensive, and his

administration is leaning on multiple federal agencies to rein

in wind development.

Revolution Wind is seeking a preliminary injunction to

restart work on the project. A hearing is scheduled for next

week.

The August stop-work order from the U.S. Bureau of Ocean

Energy Management said the project was being halted due to

unspecified national security concerns.

But in a reply to Revolution Wind's complaint last week, the

administration for the first time publicly offered more detail

on its reasoning, saying the project had failed to comply with

some conditions of its permit.

Those conditions include requirements to coordinate with

Navy vessels at sea during construction and mitigate risks to

military operations from fiber sensing and acoustic monitoring

equipment used by the project.

The Trump administration also alleged that the project has

failed to outline efforts to mitigate its impact on scientific

surveys conducted by government scientists at the National

Oceanic and Atmospheric Administration.

Revolution Wind said it has coordinated with the Navy and

NOAA, adding that the administration's filing "belatedly asserts

- for the first time - purported failures that were not

mentioned in the Stop Work Order or identified to Revolution

Wind until they were newly advanced in this litigation, and each

of which is factually incorrect."

Revolution Wind is 80% complete with all offshore

foundations in place and 45 out of 65 wind turbines installed,

according to Orsted.

The project was scheduled to be completed next year, and was

expected to produce enough electricity to power 350,000 homes in

Rhode Island and Connecticut.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Telos Insider Sold Shares Worth $408,154, According to a Recent SEC Filing
Telos Insider Sold Shares Worth $408,154, According to a Recent SEC Filing
Mar 20, 2026
04:31 AM EDT, 03/20/2026 (MT Newswires) -- Edward Hutchinson Robbins Jr., Executive Vice President and General Counsel, on March 17, 2026, sold 101,623 shares in Telos ( TLS ) for $408,154. Following the Form 4 filing with the SEC, Robbins has control over a total of 583,183 common shares of the company, with 567,278 shares held directly and 15,905 controlled...
Tarsus Pharmaceuticals Insider Sold Shares Worth $2,364,904, According to a Recent SEC Filing
Tarsus Pharmaceuticals Insider Sold Shares Worth $2,364,904, According to a Recent SEC Filing
Mar 20, 2026
04:32 AM EDT, 03/20/2026 (MT Newswires) -- Bobak R. Azamian, Director, President, Chief Executive Officer and Board Chair, on March 17, 2026, sold 34,603 shares in Tarsus Pharmaceuticals ( TARS ) for $2,364,904. Following the Form 4 filing with the SEC, Azamian has control over a total of 891,412 common shares of the company, with 33,421 shares held directly and...
Tarsus Pharmaceuticals Insider Sold Shares Worth $439,566, According to a Recent SEC Filing
Tarsus Pharmaceuticals Insider Sold Shares Worth $439,566, According to a Recent SEC Filing
Mar 20, 2026
04:31 AM EDT, 03/20/2026 (MT Newswires) -- Jeffrey S Farrow, Chief Financial Officer and Chief Strategy Officer, on March 17, 2026, sold 6,430 shares in Tarsus Pharmaceuticals ( TARS ) for $439,566. Following the Form 4 filing with the SEC, Farrow has control over a total of 43,316 common shares of the company, with 43,316 shares held directly. SEC Filing:...
Tarsus Pharmaceuticals Insider Sold Shares Worth $772,444, According to a Recent SEC Filing
Tarsus Pharmaceuticals Insider Sold Shares Worth $772,444, According to a Recent SEC Filing
Mar 20, 2026
04:30 AM EDT, 03/20/2026 (MT Newswires) -- Seshadri Neervannan, Chief Operating Officer, on March 17, 2026, sold 11,324 shares in Tarsus Pharmaceuticals ( TARS ) for $772,444. Following the Form 4 filing with the SEC, Neervannan has control over a total of 86,255 common shares of the company, with 85,780 shares held directly and 475 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1819790/000182758426000009/xslF345X05/wk-form4_1773961468.xml...